Fig. 1From: Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patientsOverview of the timeline for development of the trial platform: From the first confirmed Covid-19 case in Switzerland to the finalization of the 12 week follow-up data collectionBack to article page